english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Covid-19 : Follow Prescrire's independent, evidence-based analysis of the pandemic

Rituximab (Mabthera° or other brands) in pemphigus vulgaris: more patients in remission than with other immunosuppressants, lower exposure to corticosteroids, but a risk of cancer

In the May issue of Prescrire International: Ciclosporin eye drops (Verkazia°) in severe vernal keratoconjunctivitis

Orphan drugs: amendment needed

Medical cannabis: an experimental programme in France in 2021

Baclofen: at moderate doses, an option for some alcohol-dependent patients

Beware of "spin" in clinical trials

Larotrectinib (Vitrakvi°) and cancers with an NTRK gene fusion. Grossly inadequate evaluation as of early 2021

In the April issue of Prescrire International - Hydrochlorothiazide in hypertension: an acceptable first choice

40 years: life goes on, so does Prescrire

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90